BioNexus Gene Lab Corp (BGLC) Company Profile & Statistics

BioNexus Gene Lab Corp
BGLC
(Nasdaq - US)
Open
0.37
-0.01 (-1.91%)
in:usd•As of: Nov 04, 2024 14:40 UTC -5
Open
0.37
High
0.37
Low
0.37

About BioNexus Gene Lab Corp

CEO

Su-Leng Tan Lee

Headquarters

10-2 tower b, vertical business suite, 8 jalan kerinchi

kuala lumpur, n8 59200, malaysia

Auditor

JP CENTURION & PARTNERS PLT

Employees

Share Holders

324

Website

www.bionexusgenelab.com

Industry

wholesale distributors

Sector

distribution services

Company Overview

BioNexus Gene Lab Corp. is an emerging company in the business of selling chemical raw materials principally in the Southeast Asia region and the development of biopsy tests for early diagnosis and personalized health management. BioNexus Gene Lab Corp. is based in KUALA LUMPUR, Malaysia.

BioNexus Gene Lab Corp Statistics

Valuation Measures

Market Capitalization ²	6.65M
Enterprise Value	4.50M
Enterprise Value/EBITDA (ttm)	-2.28
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.70
Price to Sales (ttm)	0.74
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	13.89%
Operating Margin (ttm)	-24.01%
Profit Margin (ttm)	-20.72%
Return on Equity (ttm)	-23.07%
Return on Invested Capital (ttm)	-22.76%
Return on Assets (ttm)	-19.53%

Income Statement

Revenue (ttm)	9.18M
Revenue Per Share (ttm)	0.51
Gross Profit (ttm)	1.27M
EBITDA (ttm)³	-1.97M
Net Income Avi to Common (ttm)	-2.21M
Diluted EPS (ttm)	N/A

Share Statistics

Beta (5Y Monthly)	7.71
52-Week Change	-6.57%
S&P500 52-Week Change	31.99%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	17.97M
Dividend Yield	0.00%
Float ⁴	17.61M
% Held by Insiders	2.02%
% Held by Institutions	18.85%

Balance Sheet

Total Cash (mrq)	5.41M
Total Cash Per Share (mrq)	0.30
Total Debt (mrq)	53.20K
Total Debt/Equity (mrq)	0.56%
Current Ratio (mrq)	5.60%
Quick Ratio (mrq)	4.87%
Book Value Per Share (mrq)	0.54

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.04
Free Cash Flow (ytd)	-431.10K

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

BioNexus Gene Lab Corp

Trade With A Regulated Broker